Laboratorios Alfa, SRL · 66-41 · DOMINICAN REPUBLIC (THE)
For Laboratorios Alfa, SRL · 66-41 · DOMINICAN REPUBLIC (THE), import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is DOMINICAN REPUBLIC (THE); product is Resfridol | Resfridol | Resfridol | Resfridol | Resfridol; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 60 L - - -- Analgesic | 61 X - - -- A-Histaminic | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/28/2022; address is Calle La Isabela , Km. 14, Autopista Duarte , Santo Domingo De Guzman, Distrito Nacional DOMINICAN REPUBLIC (THE), verified against its source on 2026-09-16.
- Firm
- Laboratorios Alfa, SRL verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- DOMINICAN REPUBLIC (THE) verified
- Address
- Calle La Isabela , Km. 14, Autopista Duarte , Santo Domingo De Guzman, Distrito Nacional DOMINICAN REPUBLIC (THE) verified
- Date published
- 06/28/2022 verified
- Product code
- 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 60 L - - -- Analgesic | 61 X - - -- A-Histaminic | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Resfridol | Resfridol | Resfridol | Resfridol | Resfridol each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. each item verified
What the source says
Laboratorios Alfa, SRL Date Published : 06/28/2022 Calle La Isabela , Km. 14, Autopista Duarte , Santo Domingo De Guzman, Distrito Nacional DOMINICAN REPUBLIC (THE) 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 06/28/2022 Desc: Resfridol Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 06/28/2022 Desc: Resfridol Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. 60 L - - -- Analgesic Date Published: 06/28/2022 Desc: Resfridol Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. 61 X - - -- A-Histaminic Date Published: 06/28/2022 Desc: Resfridol Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/28/2022 Desc: Resfridol Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘ANTI-FLU’; ‘Nasal congestion’; ‘Headaches’; ‘Fever’; ‘Sneezing and tearing’.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html